Symphony Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,653
| Closed | -$215K | – | 195 |
|
|
2018
Q2 | $215K | Sell |
2,653
-2,483
| -48% | -$201K | 0.04% | 221 |
|
|
2018
Q1 | $417K | Sell |
5,136
-1,314
| -20% | -$107K | 0.05% | 263 |
|
|
2017
Q4 | $575K | Sell |
6,450
-144
| -2% | -$12.8K | 0.06% | 238 |
|
|
2017
Q3 | $614K | Buy |
6,594
+129
| +2% | +$12K | 0.07% | 238 |
|
|
2017
Q2 | $587K | Buy |
6,465
+73
| +1% | +$6.63K | 0.07% | 248 |
|
|
2017
Q1 | $561K | Buy |
6,392
+1,849
| +41% | +$162K | 0.05% | 267 |
|
|
2016
Q4 | $377K | Sell |
4,543
-915
| -17% | -$75.9K | 0.04% | 327 |
|
|
2016
Q3 | $505K | Sell |
5,458
-117
| -2% | -$10.8K | 0.05% | 264 |
|
|
2016
Q2 | $434K | Sell |
5,575
-190
| -3% | -$14.8K | 0.05% | 251 |
|
|
2016
Q1 | $476K | Buy |
+5,765
| New | +$476K | 0.05% | 255 |
|
|
2014
Q2 | – | Sell |
-4,414
| Closed | -$301K | – | 400 |
|
|
2014
Q1 | $301K | Buy |
4,414
+385
| +10% | +$26.3K | 0.03% | 369 |
|
|
2013
Q4 | $283K | Buy |
+4,029
| New | +$283K | 0.02% | 372 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 351 |
|